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Co-infection of tuberculosis and parasitic diseases in humans is an important public problem in co-endemic areas
in developing countries. However, there is a paucity of studies on co-infection and even fewer reviews. This review
examines 44 appropriate papers by PRISMA from 289 papers searched in PubMed via the NCBI Entrez system (no
grey literature) up to December 2012 in order to analyze the factors that influence epidemic and host’s immunity
of co-infection. The limited evidence in this review indicates that most common parasite species are concurrent
with Mycobacterium tuberculosis in multiple organs; socio-demographics such as gender and age, special
populations with susceptibility such as renal transplant recipients, patients on maintenance haemodialysis, HIV
positive patients and migrants, and living in or coming from co-endemic areas are all likely to have an impact on
co-infection. Pulmonary tuberculosis and parasitic diseases were shown to be risk factors for each other. Co-infection
may significantly inhibit the host’s immune system, increase antibacterial therapy intolerance and be detrimental to the
prognosis of the disease; in addition, infection with parasitic diseases can alter the protective immune response to
Bacillus Calmette-Guerin vaccination against Mycobacterium tuberculosis.
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Rationale
Both tuberculosis (TB) and parasitic diseases in humans
are infectious diseases that exhibit an extensive distribu-
tion, causing serious harm to humans. The World Health
Organization Special Programme for Research and Train-
ing in Tropical Diseases (WHO TDR) provided the TDR
disease portfolio in 1999 to deal with the deterioration in
the health situation, including leprosy, TB and eight kinds
of parasitic diseases, such as malaria, schistosomiasis, etc.
[1]. WHO estimated that there was about one third of the
global population infected by TB, and in 2010, there were
an estimated 8.8 million incident cases of TB globally,
mostly occurring in Asia (59%) and Africa (26%) [2].
Meanwhile, in 2009 WHO also reported that there were
an estimated 225 million malaria cases, mainly distributed
in Africa (78%), South-East Asia (15%) and the Eastern
Mediterranean (5%) [3]. In 2012, there were an estimated* Correspondence: xiaonongzhou1962@gmail.com
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reproduction in any medium, provided the or436 million people at risk of Schistosomiasis haematobium
infection in Sub-Saharan Africa, of which 112 million were
infected, with an estimated 393 million people at risk of
Schistosomiasis mansoni infection, of which 54 million
were infected [4]; an estimated 120 million people in trop-
ical and subtropical areas of the world were infected with
lymphatic filariasis in 2009 [5]. These figures suggest that
there is an overlap of endemic regions between TB and
parasitic disease, which may lead to co-infection of these
diseases in the population.
The earliest report we found was from 1945 and
interpreted how to treat a pulmonary TB (PTB) case
running concurrently with malaria [6]. A report from
1946 described co-existence of TB with hookworm [7].
The co-infection of TB and parasitic diseases have been
reported in many studies for almost the past 70 years,
although great achievements have been gained in the
fields of TB and parasitic disease control and prevention
respectively [2-5]. Up to 2012, some cases of co-infection
between TB and parasitic diseases were reported around
the world [8-29], and some epidemiological surveys of
co-infection in hospitals or communities were carried
out [30-34]. Some of these studies showed that theLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 Search strategy and terms used to identify
studies on co-infection between TB and common
parasitic diseases
Term 1. tuberculosis, 2. parasite, 3. helminth, 4. amoebiasis,
5. leishmaniasis, 6. trypanosomiasis, 7. giardiasis, 8. trichomoniasis,
9. malaria, 10. toxoplasmosis, 11. cryptosporidiosis, 12. clonorchiasis,
13. opisthorchiasis, 14. fasciolopsiasis, 15. fascioliasis,
16. paragonimiasis, 17. schistosomiasis, 18. sparganosis,
19. echinococcosis, 20. ascariasis, 21. trichuriasis, 22. enterobiasis,
23. hookworm, 24. strongyloidiasis, 25. trichinellosis, 26. filariasis,
27. dracunculiasis
Strategy 1 and (2 or 3 or 4 or 5 or 6 or 7 or 8 or 9 or 10 or 11 or 12 or
13 or 14 or 15 or 16 or 17 or 18 or 19 or 20 or 21 or 22 or
23 or 24 or 25 or 26 or 27)
Figure 1 Study selection information regarding co-infection
between TB and parasitic diseases.
Li and Zhou Parasites & Vectors 2013, 6:79 Page 2 of 12
http://www.parasitesandvectors.com/content/6/1/79immune response was modified in the co-infection
situation [35-51].
Inevitably, co-infection would increase the complexity
of control and prevention on TB and parasitic diseases.
The current systematic reviews on the co-infection of
TB and parasitic diseases help to clarify the complexity
of co-infections; however, there are only a few systematic
reviews on co-infection. We only found that Enwere et al.
[35] reviewed the host response of co-infection between
TB and malaria and 4 reviews focused on the influ-
ence of chronic helminth infections on immunity against
TB [44,45,47,48].
Objectives
This paper reviewed studies globally over the past 70 years
on the co-infection of TB and parasitic diseases using
Preferred Reporting Items for Systematic Reviews and
Meta-Analyses (PRISMA) guidelines [52], in order to
learn more about which parasites are concurrent with TB,
the epidemiological situation regarding co-infection, and
the human immune function affected by co-infection.
Methods
Protocol and registration
We did not register the protocol for this review.
Eligibility criteria
Published articles were included if they involved case
reports of co-infection with TB and any parasitic diseases
in human participants, or epidemiological surveys of co-
infection in populations, or clinical or laboratory research
on the immune responses during co-infection, were eli-
gible for inclusion in the systematic review. Journal articles
published with full text or abstracts in English before
2013 were eligible for inclusion.
Information sources
We mainly searched PubMed via the NCBI Entrez sys-
tem (any date to December, 2012) (http://www.ncbi.nlm.
nih.gov) for studies on the association between TB and
parasitic diseases. We also searched bibliographies of
identified reports, including previous reviews, for add-
itional references.
Search
The search was limited to studies of human beings or
animal models and no language limits were applied. The
terms that were used as MeSH terms or Direct keywords
for the search and our search strategy are described in
Table 1. All titles, abstracts and full texts from each of
the searches were examined and reviewed.
Study selection
The study selection process is illustrated in Figure 1.Papers that were not co-infection studies, or were not
for humans, or were published in non-English language
without an abstract in English, were excluded. Eligible
papers were tabulated.Data collection process
Two reviewers extracted data from each eligible study
independently, and differences were resolved by discus-
sion with a third. Extracted data was tabulated on the
basis of data items. No formal meta-analysis was carried
out and analysis to investigate statistical heterogeneity or
publication bias was not performed because most of the
studies were case reports and immunological research,
and there were very few epidemiological surveys.Data items
Data extracted included country, year, co-infection of dis-
eases, sex, age, human immunodeficiency virus (HIV) test
and medical history for case reports. For epidemiological
Table 2 Case reports of co-infection between TB and parasitic diseases
Country Year of
report
Tuberculosis Parasitic disease Sex Age HIV test Supplement No. of
reference
Spain 1996 Renal TB Visceral leishmaniasis Male 44 years Negative Haemodialysis for 19 months [8]
Brazil 2001 PTB Visceral leishmaniasis Male 29 years Negative Pneumocystis carinii positive [9]
Turkey 2003 PTB Visceral leishmaniasis Male 39 years Negative Renal transplantation in 2001; Anti-HCV and HCV RNA positive [10]
India 2005 PTB Visceral leishmaniasis Male 37 years Positive Tuberculoma of brain [11]
India 2006 PTB Visceral leishmaniasis Female 40 years Positive [12]
India 2006 PTB Visceral leishmaniasis Male 40 years Positive [12]
Colombia 1996 PTB Mucocutaneous
leishmaniasis
Male 50 years Negative [13]
France 2003 PTB Cutaneous leishmaniasis Male 44 years Negative A migrant from Brazil; Polar lepromatous leprosy [14]
Sri Lanka 2010 Extrapulmonary TB Mucosal leishmaniasis Male 52 years Negative T-lymphocyte subsets: CD3-437, CD4-237, CD8-146 μl; Serum IgG-532 and
IgM-36 mg/dl
[15]
India 2010 PTB Post-kala-azar dermal
leishmaniasis
Female 25 years Positive On treatment for leprosy and PTB for the past 2 months [16]
France 2000 Lymph node TB Lymph node
trichomoniasis
Female 82 years Negative [17]
India 2010 PTB Perinatal falciparum
malaria
Female 34 days Unknown Maternal history of falciparum malaria during eighth month of pregnancy;
Father was smear-positive PTB case.
[18]
Haiti 1984 PTB Toxoplasmosis Male 27 years Unknown Toxoplasmosis proved fatal and was diagnosed only at autopsy. [19]
Sri Lanka 2011 Lymph node TB Toxoplasmosis
Toxocariasis
Male 4 years Negative [20]
Korea 2012 Disseminated TB Cerebral toxoplasmosis Male 24 years Unknown A non-Korean engineer with abdominal TB [21]




Male 30 years A migrant from the Philippines; A history of alcohol abuse [22]
India 1991 PTB Hydatid disease Female 5 years Unknown [23]
Turkey 2002 PTB Cardiac hydatid cyst Female 52 years Negative [24]




Female 28 years Negative [25]
Sudan 2009 PTB Hydatid disease Female 25 years Unknown In a solitary pulmonary nodule of left lower lobe [26]
China 2009 PTB Liver echinococcosis Male 18 years Unknown PTB was previously confirmed in 2000 and found relapse in 2008. [27]
China 2009 PTB Liver echinococcosis Female 36 years Unknown PTB was previously confirmed in 1998 and found relapse in 2008. [27]
Britain 1994 PTB Strongyloidiasis Giardiasis Male 31 years Unknown A migrant from Gambia; Being resident in the United Kingdom for two years [28]
India 2001 TB verrucosa cutis Filarial elephantiasis Male 55 years Unknown [29]
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year, survey site, number of population screened, number
of people with PTB, number of people with parasitic dis-
ease, number of people co-infected and prevalence. For
clinical or laboratory research on immunity during co-
infection, we collected detailed information on country,
year, co-infection of disease, subject and conclusions.
Summary measures
Risk ratios (RR) and their 95% confidence intervals (CI)
were calculated using the Statistical Analysis System
(SAS 9.2; SAS Institute Inc., Cary, NC, USA) through
Chi square test. All P-values of <0.05 were taken as sta-
tistically significant.
Results
Two hundred and eighty nine papers were retrieved
from the search of published work, of which, 10 were
excluded because of duplication and 235 were irrelevant
to co-infection with TB and parasitic diseases. Finally,
44 studies of co-infection were included in the analysis,
of which, 22 were case reports, 5 were epidemiological
surveys and 17 were immunological research/reviews
(Figure). There was no grey literature included.
Table 2 summarizes the case reports of co-infection.
Twenty-four cases were reported in 22 studies from 13
countries during 1984 to 2012, in which 7 cases were
from India. Fourteen studies investigated co-infection
with PTB and parasites diseases and 8 studies involved
the extrapulmonary TB, such as renal TB, lymph node
TB, abdominal TB, TB in liver, tuberculous lymphaden-
itis and TB verrucosa cutis. The youngest case reported
was 34 days old and the eldest case was 82 years old,
and the median age of all cases reported was 36 years
old. Fifteen of a total 24 cases were male. Ten patients
with different clinical conditions co-infected with TB
and leishmaniasis were reported, of which, visceral leish-
maniasis was the highest. There were also 6 cases co-
infected with TB and hydatid disease. In addition,
parasitic diseases accompanied by TB included tricho-
moniasis, malaria, toxoplasmosis, toxocariasis, schisto-
somiasis, strongyloidiasis and filarial elephantiasis in
different organs. Fourteen of a total of 24 cases reported
had been tested for HIV test and 4 were positive.
It can be seen in Table 3 that 5 studies from 3 East
African countries and 1 East Asian country were conducted
for epidemiology of co-infection between TB and parasitic
diseases during 1984 to 2012. Two studies screened across
the general population with 382 and 782 participants in a
community and a hospital respectively, one study showed
329 and 215 PTB patients in two hospitals respectively,
one study showed 309 PTB patients who were HIV posi-
tive and 346 who were HIV negative in a hospital, in the
other study, there were 112 smear positive TB patientsin a town, whose parasite species involved Entamoeba
histolytica, Leishmania donovani, Giardia lamblia, mal-
aria, Clonorchis sinensis, Schistosoma mansoni, taenia
species, Ascaris lumbricoides, Trichocephalus trichiurus,
hookworm and Strongyloides stercoralis. The prevalence
of co-infection between TB and parasitic diseases varied
widely among different participants, s species or survey
sites.
The interrelationship of infection with TB and para-
sitic diseases have been evaluated in Table 4 through
two studies screened in the general population, with
382 and 782 participants in a community and a hospital
respectively. Those who were Leishmania donovani posi-
tive, Giardia lamblia positive or Strongyloides stercoralis
positive more easily suffered from PTB than those who
were negative and RR values (95% CI) were 1.73 (1.14-
2.62), 1.80 (1.10-2.93) and 3.11 (1.53-6.35), respectively.
Likewise, persons with PTB were more easily infected by
Leishmania donovani, Giardia lamblia or Strongyloides
stercoralis than persons without PTB and RR values
(95% CI) were 1.24 (1.08-1.43), 1.86 (1.09-3.16) and 4.26
(1.42-12.77), respectively.
Immunological research of co-infection between TB
and parasitic diseases during 1989 to 2012 are shown in
Table 5. In four studies that reported a change of activity
of the host’s immune system when the course of TB was
aggravated by opisthorchiasis invasion, the activity in-
creased at the acute stage of invasion and decreased at
the subacute stage or in the chronization. A study from
France showed that co-infecton of American cutaneous
leishmaniasis, lepromatous leprosy and PTB downregulated
the T-helper (Th) 1 cell response. Four studies on co-
infection with Mycobacterium tuberculosis (M. TB) and
malaria showed that malarial parasites decreased the host’s
effective humoral and cellular immune responses to M. TB,
and co-infection exacerbated chronic TB, suggesting a
competitive antagonist effect between heat shock protein
70 (HSP70) from M. TB and adenosine triphosphate-
binding protein (ATPBP) of malaria may exist. Two studies
suggested that the impact of co-infection between filarial
infection and M. TB infection on the immune response
was uncertain. Four studies reported immunomodulation
characteristics of co-infection beween TB and intestinal
helminths. A study from China indicated that as the echi-
nococcosis chronicity increased, the immune profile in TB
patients changed from a Th1 to Th2 response. In three
other studies in which the effect of infection of intestinal
parasites and Schistosoma mansoni on the protective im-
mune response to Bacillus Calmette-Guerin (BCG) vaccin-
ation against M. TB and the effect of malaria infection on
the effectiveness of novel TB vaccines in protecting against
TB were evaluated, the protective efficacy of BCG vac-
cination was reduced but the effectiveness of novel TB
vaccines was unaffected.











HIV test No. of
referenceNo. Species d/a d/b d/c
Korea 1984 329 Trichocephalus trichiurus 68 20.7 Hospital1 Unknown [30]
215 Trichocephalus trichiurus 14 6.5 Hospital2 Unknown
329 Clonorchis sinensis 58 17.6 Hospital1 Unknown
215 Clonorchis sinensis 13 6.0 Hospital2 Unknown
Sudan 2004 382 100 252 Leishmania donovani 77 20.2 77.0 30.6 Community Unknown [31]
Ethiopia 2006 782 100 234 Intestinal parasites 32 4.1 32.0 13.7 Hospital Unknown [32]
782 100 155 Helminths 16 2.0 16.0 10.3 Hospital Unknown
Parasites species
782 100 88 Ascaris lumbricoides 5 0.6 5.0 5.7 Hospital Unknown
782 100 70 Giardia lamblia 15 1.9 15.0 21.4 Hospital Unknown
782 100 50 Entamoeba histolytica 10 1.3 10.0 20.0 Hospital Unknown
782 100 36 Hookworm 6 0.8 6.0 16.7 Hospital Unknown
782 100 25 Taenia species 2 0.3 2.0 8.0 Hospital Unknown
782 100 13 Strongyloides stercoralis 5 0.6 5.0 38.5 Hospital Unknown
782 100 8 Trichuris trichiura 1 0.1 1.0 12.5 Hospital Unknown
Tanzania 2007 309 Malaria 19 6.1 Hospital HIV positive [33]
309 Schistosomiasis 100 32.4 Hospital HIV positive
309 Hookworm 33 10.7 Hospital HIV positive
346 Malaria 9 2.6 Hospital HIV negative
346 Schistosomiasis 132 38.2 Hospital HIV negative
346 Hookworm 86 24.9 Hospital HIV negative




112 Ascaris lumbricoides 12 10.7 Community
112 Hookworm 8 7.1 Community
112 Schistosoma mansoni 6 5.4 Community
112 Trichuris trichiura 8 7.1 Community
















Table 4 The interrelationship of infection between TB and parasitic diseases
Country Year of report Parasitic disease PTB (+) PTB (−) RRrow (95% CI) P-value No. of reference
Sudan 2004 Leishmania donovani + 77 175 1.73 (1.14-2.62) [31]
_ 23 107 1.00
RRcol (95% CI) 1.24 (1.08-1.43) 1.00 0.0067
Ethiopia 2006 Intestinal parasites + 32 202 1.10 (0.74-1.63) [32]
_ 68 480 1.00
RRcol (95% CI) 1.08 (0.79-1.47) 1.00 0.6272
Helminths + 16 139 0.77 (0.46-1.28)
_ 84 543 1.00
RRcol (95% CI) 0.78 (0.49-1.26) 1.00 0.3047
Ascaris lumbricoides + 5 83 0.42 (0.17-0.99)
_ 95 599 1.00
RRcol (95% CI) 0.41 (0.17-0.99) 1.00 0.0341
Giardia lamblia + 15 55 1.80 (1.10-2.93)
_ 85 627 1.00
RRcol (95% CI) 1.86 (1.09-3.16) 1.00 0.0233
Entamoeba histolytica + 10 40 1.63 (0.90-2.93)
_ 90 642 1.00
RRcol (95% CI) 1.70 (0.88-3.30) 1.00 0.1145
Hookworm + 6 30 1.32 (0.62-2.81)
_ 94 652 1.00
RRcol (95% CI) 1.36 (0.58-3.19) 1.00 0.4451
*
Taenia species + 2 23 0.62 (0.16-2.36)
_ 98 659 1.00
RRcol (95% CI) 0.59 (0.14-2.48) 1.00 0.7594
*
Strongyloides stercoralis + 5 8 3.11 (1.53-6.35)
_ 95 674 1.00
RRcol (95% CI) 4.26 (1.42-12.77) 1.00 0.0172
*
Trichuris trichiura + 1 7 0.98 (0.15-6.17)
_ 99 675 1.00
RRcol (95% CI) 0.97 (0.12-7.84) 1.00 1.0000
*
















Table 5 Immunological research of co-infection between TB and parasitic diseases
Country Year of
report
Tuberculosis Parasitic disease/species Subject Conclusions No. of
reference
France 2003 PTB American cutaneous
leishmaniasis
A 44-year-old man with triple infection of
cutaneous leishmaniasis, lepromatous leprosy,
and PTB
Unresponsiveness to IL-12 of patient’s T cells after stimulation with
Leishmania guyanensis, M. bovis bacille Calmette-Guerin, and M. leprae
antigens suggested the inability to mount an appropriate Th cell
response to upregulate the IL-12 receptor expression.
[14]
Gambia 1999 M. TB Malaria Review Malarial parasites can decrease their vertebrate host’s effective humoral
and cellular immune responses to M. TB.
[35]
USA 2004 M. TB Plasmodium yoelii NL Mice Co-infected mice were less able to contain growth of M. TB in lung,
spleen, and liver and had increased mortality.
[36]
Thailand 2006 M. TB Plasmodium falciparum HSP70 (M. TB) and ATPBP (Plasmodium
falciparum)
HSP70 and ATPBP share a common molecular function as ATP binding
resulting from purine nucleotide binding. Therefore, a competitive
antagonist effect between both molecules can be expected.
[37]
Germany 2012 M. TB Plasmodium berghei NK65 An experimental mouse model of co-infection Co-infection exacerbated chronic TB while rendering mice less
refractory to Plasmodium. Co-infected animals presented with
enhanced inflammatory immune responses as reflected by exacerbated
leukocyte infiltrates, tissue pathology and hypercytokinemia
accompanied by altered T-cell responses.
[38]
Unknown 1989 PTB Opisthorchiasis 173 patients with PTB complicated by
opisthorchiasis
Among them, activity of the α1-proteinase inhibitor was more
frequently higher and carriers of two markers i.e. Hp 2–2 and Gc 1–1
were more frequent.
[39]
Unknown 1992 PTB Opisthorchiasis 12 PTB patients concurrent with opisthorchiasis When the course of TB is aggravated by opisthorchiasis invasion, the
number of cases of antibacterial therapy intolerance increases and
prognosis of the diseases deteriorates. It was shown that the
antibacterial and anthelminthic therapy had a favourable clinical and
immunologic effect.
[40]
Unknown 1992 M. TB Opisthorchiasis Animal In comparison with the groups of animals with monoinvasion and
monoinfection, at the acute invasive phase of mixed pathology
(2 weeks) the activity of the host’s immune system increases, while the
biological activities of both pathogens decrease; however, at the
subacute phase (2.5 months), all were contrary respectively.
[41]
Russia 2003 TB Opisthorchiasis Golden hamsters with SRBC parasitocenosis In cases of mixed pathology, at the acute stage of invasion, the
immune system showed increased responses with respect to specific
and heterologous antigens; in the chronization of invasion the
formation of antibodies to heterologous antigens (SRBC) and the level
of specific antiopisthorchiasis and anti-TB immune responses decreased
together.
[42]
China 2009 PTB Echinococcosis A 18 years old male and a 36 years female As the echinococcosis chronicity increased, the immune profile in both
subjects changed from a Th1 to Th2 response. Such an elevated Th2
immune profile, with subsequent suppression of the Th1 immune
response, is a common feature of chronic helminth infections.
[27]
USA 2012 M. TB Litomosoides sigmodontis Cotton rats with chronic L. sigmodontis
infection and uninfected controls were
challenged with M. TB by intranasal
inoculation.
Chronic filarial infections do not exacerbate M. TB infection in the
cotton rat model. It may be possible to develop worm-derived
therapies for autoimmune diseases that do not substantially increase

















Table 5 Immunological research of co-infection between TB and parasitic diseases (Continued)
USA 2012 M. TB Filarial infections Review Filarial infections very clearly alter the magnitude and quality of the
mycobacteria-specific cytokine responses, responses that have been
typically associated with control of these intracellular pathogens.
[44]
Denmark 2007 TB Intestinal helminth Review Co-infections cause a range of immunomodulation characterized by
enhanced Th2-type cytokine profiles, high IgE levels and upregulated
regulatory T-cell activity, as well as chronic immune activation.
[45]
Brazil 2007 PTB Intestinal helminth 40 PTB patients and 25 healthy controls Compared to either TB patients or healthy controls, co-infected
patients’ absolute frequencies of CD3+, CD4+, CD8+, NK T cell and CD4
+CD25high T cell increased. Differences in CD4 T cell frequencies were
accompanied by lower IFN-γ and elevated and sustained IL-10 levels in
WB cultures from co-infected patients compared to TB patients.
[46]
Mexico 2012 TB Helminthic infections Review Helminths very clearly alter the magnitude of the mycobacteria-specific
cytokine responses, altering the control of the mycobacteria growth.
Mycobacteria-induced immune responses are suppressed by helminth
infections.
[47]
USA 2012 TB Helminths Review Helminth-induced Th2 and T reg responses impinge on host resistance
against M. TB infection. Th1 response is reduced in helminth co-
infected hosts. Helminth-induced alternatively activated macrophages







14 male students aged 12–15 years: 7 having
protozoan or helminthic infections and 7 free
of intestinal parasites
Th2-like IL-10 responses induced by intestinal parasites may interfere in
BCG-induced Th1-like IFN-γ response. Intestinal parasitic infections may






S. mansoni BCG vaccinated mice with prior S. mansoni
infection
S. mansoni infection reduces the protective efficacy of BCG vaccination
against M. TB possibly by attenuation of protective immune responses
to mycobacterial antigens and/or by polarizing the general immune
responses to the Th2 profile.
[50]
USA 2011 TB vaccines in
protecting
against M. TB
Plasmodium yoelii NL TB vaccines in a co-infection mouse model of
two pathogens
The effectiveness of novel TB vaccines in protecting against TB was
unaffected by a primary malaria co-infection in a mouse model of PTB.
[51]
Abbreviations: PTB = pulmonary tuberculosis; M. leprae = mycobacterium leprae; M. TB = mycobacterium tuberculosis; SRBC = sheep red blood cells; IL = interleukin; Th = T helper; Treg = T regulatory; NL = non-lethal;
HSP = heat shock protein; ATP = adenosine triphosphate; ATPBP = ATP-binding protein; Ig = immunoglobulin; CD = cluster of differentiation; NK = natural killer; IFN = interferon; WB = whole blood; BCG = Bacillus
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This review only found 24 cases of co-infection with TB
and parasitic diseases but they distributed widely in 13
countries and covered PTB, extrapulmonary TB, and
diseases caused by protozoa and helminths [8-29]. We
also found 5 epidemiological studies in which prevalence
of co-infection varied widely [30-34], and found that it
was evident in 18 studies that the activity of the host’s
immune system was altered during co-infection hap-
pened [27,34-42,44-51]. Therefore, assessing co-infection
characteristics, influencing factors and impact on im-
munity is important to control and prevention whether
for TB or parasitic diseases.
About 17 parasite genera concurrent with M. TB
were reviewed as case reports, epidemiological surveys
and immunological research, which were divided into
protozoa (Entamoeba [32,49], Leishmania [8-16,31],
Giardia lamblia [28,32], Trichomonas [17], Plasmo-
dium [18,33,35,37,38], Toxoplasma [19-21]) and hel-
minths (Clonorchis sinensis [30], Opisthorchis [39,40],
Schistosoma [22,33,34], Taenia [32], Echinococcus [23-27],
Ascaris lumbricoides [32,34,49], Toxocara [20], Trichuris
trichiura [30,32,34], Ancylostoma [32-34], Strongyloides
stercoralis [28,32,34,49], Filaria [29,43,44]) and covered
most of the common parasites species. Of those, leish-
maniasis, hydatid disease and malaria were reported to
coexist more freuequently with TB in the human body.
In addition to co-infection of TB and a single parasitic
disease, there was also co-infection of TB and multiple
parasitic diseases, such as co-infection of pneumocystis
carinii pneumonia, visceral leishmaniasis and PTB, co-
infection of toxoplasmosis, toxocariasis and TB, and
co-infection of strongyloidiasis, giardiasis and TB [9,20,28].
Possibly gender differences exist in co-infection of TB
and different parasitic diseases. Among ten cases reported
to be co-infected with TB and leishmaniasis, only two
cases were female [8-16], however, only one of six cases
co-infected with TB and hydatid disease was male [23-27].
In spite of these limited data without epidemiological
evidence, we can infer that different social roles asso-
ciated by gender possibly result in different probabilities
of contacting different parasites resulting in different
incidence and prevalence. An epidemiological survey
in subtropical Ecuador suggested that male gender was
one of risk factors associated with cutaneous leish-
maniasis [53]. Contrarily, a population-based study in
the Hamar of Ethiopia indicated that hydatid disease
was a public health problem for women [54]. Irrefut-
ably, gender differentials also exist in the prevalence
of TB [55].
Although no significant age clustering was found in
23 cases of co-infecion who had a huge age span ran-
ging from 34 days old to 82 years old [8-29], however,
there were fewer reported cases of less than 20 yearsold and more than 60 years old. Likewise, this limited
data were not epidemiological results. Nevertheless,
age differentials of co-infection also exist and should
not be a neglected factor. A cross-sectional household
survey in Sudan showed that percentages of leishmania
skin tests and tuberculin positivity by age group increased
[31], which possibly reflects that with the increasing age,
not only does the immune response increase following
exposure to infection but also opportunities of exposure
to infection increase gradually.
Among TB patients, prevalence of parasitic disease var-
ies widely in different areas and different survey sites. TB
and parasitic disease co-infection is common in clinical
practice in East Africa. In Sudan, up to 77% of TB patients
were positive for the leishmania skin test in the commu-
nity [31]; 32% of TB patients from hospitals had intestinal
parasites and 29% of TB patients from the community
had intestinal helminths in Ethiopia [32,34]; and 32.4-
38.2% of TB patients from hospitals were also infected
with Schistosomes in Tanzania [33]. We also noticed
the prevalence differentials in Korea, where the infec-
tion rates of Trichocephalus trichiurus and Clonorchis
sinensis were 20.7% and 17.6% respectively among TB
patients in one hospital, but the infection rates were
6.5% and 6.0% respectively in another hospital [30]. Among
the PTB patients from a hospital in Tanzania, the HIV-
positive patients had a significantly lower prevalence
of hookworm and Schistosome infection and a higher
prevalence of malaria than the HIV-negative patients
[33], which indicates HIV also has an impact on preva-
lence of co-infection.
Therefore, it is no surprise to find many factors that
possibly affect co-infection of TB and parasitic diseases.
First, socio-demographics, such as gender and age as
previously mentioned above, maybe relate to prevalence
of co-infection. Second, some special patients, such
as renal transplant recipients, patients on mainten-
ance haemodialysis, HIV positive patients and migrants
[8,10-12,14,16,21,22,28,33], are likely to be susceptible
populations of co-infection. Last but not least, there are
higher probabilities of co-infection in some areas with a
higher prevalence of TB and parasitic diseases, such as
India and East Africa [11,12,16,18,23,29,31-34]. These
might provide useful information to control and prevent
co-infection of TB and parasites under the background of
very few epidemiological surveys for co-infection to date.
It was observed that PTB and parasitic diseases were
risk factors for each other. We analyzed the data of an
epidemiological survey in Sudan and found that Leish-
maniasis patients had a 1.73 times higher risk for PTB
than individuals without Leishmania and PTB patients
had a 1.24 times higher risk for Leishmaniasis than indi-
viduals without PTB [31]. We also found data from an
epidemiological survey in Ethiopia that Giardiasis and
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than persons without Giardia lamblia and Strongyloides
stercoralis, respectively, and PTB patients had a higher
risk for Giardiasis and Strongyloidiasis than persons
without PTB [32].
In comparison with mono-infection, co-infection makes
the host’s immune system have to deal with a more com-
plex internal environment. The usual manifestation is that
clinical signs might become more frequent and serious
and therapy may be affected when TB patients are also
infected by parasites. Both clinical and laboratory based
studies showed that when the course of TB was aggravated
by opisthorchiasis invasion, clinical signs of TB became
more pronounced, disorders in the functions of the liver
and pancreas became more frequent, antibacterial therapy
intolerance increased and prognosis of the disease dete-
riorated [39,40]. In order to clarify these situations,
some studies were conducted to evaluate the immuno-
pathogenesis of co-infection. Limited data from two stud-
ies showed that the immune response of TB patients
increased at the acute stage of opisthorchiasis invasion
and decreased at the subacute stage or in the chronization
[41,42]. Two studies indicated that malarial parasites
decreased the hosts effective humoral and cellular im-
mune responses to M. TB [35,36], and another study
using an experimantal animal model showed co-infection
between TB and malaria exacerbated chronic TB while
rendering mice less refractory to Plasmodium [38]. An-
other study found that with the increase of echinococcosis
chronicity, the immune profile in TB patients displayed
an elevated Th2 immune reponse with subsequent sup-
pression of the Th1 immune response [27]. Although
one study suggested chronic filarial infections do not
exacerbate M. TB infection [43], a review pointed out
that filarial infections very clearly alter the magnitude
and quality of the mycobacteria-specific cytokine re-
sponse [44]. Generally, it is observed that the host’s
immune system is inhibitited to a great extent during
co-infection.
Some investigations observed the change of levels of
immune indexes during co-infection. A study on co-
infection of PTB and opisthorchiasis found that among
co-infected patients, activity of the α1-proteinase inhibi-
tor was more frequently higher and carriers of two
markers i.e. Hp 2–2 and Gc 1–1 were more frequent
[39]. A study on triple infection of leishmaniasis, TB and
leprosy showed that patients were unable to mount a Th
cell response to upregulate the interleukin-12 receptor
expression after stimulation of the triple infection [14].
The investigation of co-infection between TB and in-
testinal helminths suggested that compared to either
TB patients or healthy controls, the absolute frequen-
cies of CD3+, CD4+, CD8+, Natural killer T cell and
CD4+CD25high T cell increased in co-infected patients[46]. Indeed, the change of immune index levels re-
flects a ‘weakened’ immune response.
It is worthwhile evaluating the impact of parasitic dis-
ease infection on the efficacy of BCG vaccination against
M. TB. Ferreira et al. [49] and Elias et al. [50] found that
intestinal parasitic infections might significantly alter the
protective immune response to BCG vaccination and/or
polarize the general immune response to the Th2 profile
since Th2-like interleukin-10 responses induced by in-
testinal parasites might interfere in the BCG-induced
Th1-like interferon-γ response. Therefore, in areas of
high prevalence of co-infection, anti-parasitic chemo-
therapy prior to immunization may greatly enhance the
efficacy of BCG vaccination.Conclusion
This review has found limited evidence of factors that
influence epidemic and host’s immunity of co-infection
between TB and parasitic disease in humans. Most of the
common parasites species are concurrent with M. TB
in multiple organs, which increase antibacterial therapy
intolerance and deteriorate prognosis of disease. Socio-
demographics such as gender and age, special populations
with susceptibility, such as renal transplant recipients,
patient on maintenance haemodialysis, HIV positive
patients and migrants, and living in or coming from
co-endemic areas likely have impacts on co-infection.
PTB and parasitic diseases were shown to be risk fac-
tors for each other. Co-infection may inhibit the hosts
immune system to a great extent. In addition, infection
with parasites can alter the protective immune response
to BCG vaccination against M. TB.Competing interest
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